Search research articles
Contact Us
Filters
Showing results (1-10 of 36) with videos related to
Page
of 4
Sort By:
Biology
|
April 23, 2022
Enhancement of Antiviral T-Cell Responses by Vitamin C Suggests New Strategies to Improve Manufacturing of Virus-Specific T Cells for Adoptive Immunotherapy
Miriam Laubert, Agnes Bonifacius, Anna Christina Dragon, et al.
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie
|
February 28, 2022
Variances in Antiviral Memory T-Cell Repertoire of CD45RA- and CD62L-Depleted Lymphocyte Products Reflect the Need of Individual T-Cell Selection Strategies to Reduce the Risk of GvHD while Preserving Antiviral Immunity in Adoptive T-Cell Therapy
Caroline Mangare, Sabine Tischer-Zimmermann, Agnes Bonifacius, et al.
European Journal of Microbiology & Immunology
|
February 6, 2019
<i>Yersinia Pseudotuberculosis</i> Modulates Regulatory T Cell Stability via Injection of Yersinia Outer Proteins in a Type III Secretion System-Dependent Manner
Ahmed Elfiky, Agnes Bonifacius, Joern Pezoldt, et al.
Frontiers in Immunology
|
April 10, 2023
Reinforcement of cell-mediated immunity driven by tumor-associated Epstein-Barr virus (EBV)-specific T cells during targeted B-cell therapy with rituximab
Sabine Tischer-Zimmermann, Agnes Bonifacius, Maria Michela Santamorena, et al.
Cellular and Molecular Life Sciences : CMLS
|
April 6, 2017
Yersinia pseudotuberculosis supports Th17 differentiation and limits de novo regulatory T cell induction by directly interfering with T cell receptor signaling
Maria Pasztoi, Agnes Bonifacius, Joern Pezoldt, et al.
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie
|
January 19, 2026
Improved Antitumor Activity of Interleukin-12-Secreting Chimeric Antigen Receptor T Cells Targeting CD176 across Different Carcinomas
Melina Umland, Anna Christina Dragon, Luca Marie Beermann, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
January 12, 2025
Depletion of alloreactive B cells by drug-resistant chimeric alloantigen receptor T cells to prevent transplant rejection
Anna Christina Dragon, Agnes Bonifacius, Stefan Lienenklaus, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation
|
April 24, 2024
<i>In Vitro</i> Profiling of Commonly Used Post-transplant Immunosuppressants Reveals Distinct Impact on Antiviral T-cell Immunity Towards CMV
Markus Benedikt Krueger, Agnes Bonifacius, Anna Christina Dragon, et al.
Frontiers in Medicine
|
December 13, 2021
Long-Lasting Immunity Against SARS-CoV-2: Dream or Reality?
Daniel Gussarow, Agnes Bonifacius, Anne Cossmann, et al.
Molecular Cancer Therapeutics
|
December 19, 2025
Vitamin C conditioning generates tumor-targeting CAR T cells with superior cytotoxicity and fitness in a post-transplant lymphoproliferative disorder tumor model
Pegah Rahmati, Agnes Bonifacius, Anna Christina Dragon, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 36) with videos related to
Sort By:
Page
of 4
Biology
|
April 23, 2022
Enhancement of Antiviral T-Cell Responses by Vitamin C Suggests New Strategies to Improve Manufacturing of Virus-Specific T Cells for Adoptive Immunotherapy
Miriam Laubert, Agnes Bonifacius, Anna Christina Dragon, et al.
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie
|
February 28, 2022
Variances in Antiviral Memory T-Cell Repertoire of CD45RA- and CD62L-Depleted Lymphocyte Products Reflect the Need of Individual T-Cell Selection Strategies to Reduce the Risk of GvHD while Preserving Antiviral Immunity in Adoptive T-Cell Therapy
Caroline Mangare, Sabine Tischer-Zimmermann, Agnes Bonifacius, et al.
European Journal of Microbiology & Immunology
|
February 6, 2019
<i>Yersinia Pseudotuberculosis</i> Modulates Regulatory T Cell Stability via Injection of Yersinia Outer Proteins in a Type III Secretion System-Dependent Manner
Ahmed Elfiky, Agnes Bonifacius, Joern Pezoldt, et al.
Frontiers in Immunology
|
April 10, 2023
Reinforcement of cell-mediated immunity driven by tumor-associated Epstein-Barr virus (EBV)-specific T cells during targeted B-cell therapy with rituximab
Sabine Tischer-Zimmermann, Agnes Bonifacius, Maria Michela Santamorena, et al.
Cellular and Molecular Life Sciences : CMLS
|
April 6, 2017
Yersinia pseudotuberculosis supports Th17 differentiation and limits de novo regulatory T cell induction by directly interfering with T cell receptor signaling
Maria Pasztoi, Agnes Bonifacius, Joern Pezoldt, et al.
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie
|
January 19, 2026
Improved Antitumor Activity of Interleukin-12-Secreting Chimeric Antigen Receptor T Cells Targeting CD176 across Different Carcinomas
Melina Umland, Anna Christina Dragon, Luca Marie Beermann, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
January 12, 2025
Depletion of alloreactive B cells by drug-resistant chimeric alloantigen receptor T cells to prevent transplant rejection
Anna Christina Dragon, Agnes Bonifacius, Stefan Lienenklaus, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation
|
April 24, 2024
<i>In Vitro</i> Profiling of Commonly Used Post-transplant Immunosuppressants Reveals Distinct Impact on Antiviral T-cell Immunity Towards CMV
Markus Benedikt Krueger, Agnes Bonifacius, Anna Christina Dragon, et al.
Frontiers in Medicine
|
December 13, 2021
Long-Lasting Immunity Against SARS-CoV-2: Dream or Reality?
Daniel Gussarow, Agnes Bonifacius, Anne Cossmann, et al.
Molecular Cancer Therapeutics
|
December 19, 2025
Vitamin C conditioning generates tumor-targeting CAR T cells with superior cytotoxicity and fitness in a post-transplant lymphoproliferative disorder tumor model
Pegah Rahmati, Agnes Bonifacius, Anna Christina Dragon, et al.
Page
of 4